Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor
- PMID: 32225176
- DOI: 10.1038/s41586-020-2180-5
Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor
Abstract
A new and highly pathogenic coronavirus (severe acute respiratory syndrome coronavirus-2, SARS-CoV-2) caused an outbreak in Wuhan city, Hubei province, China, starting from December 2019 that quickly spread nationwide and to other countries around the world1-3. Here, to better understand the initial step of infection at an atomic level, we determined the crystal structure of the receptor-binding domain (RBD) of the spike protein of SARS-CoV-2 bound to the cell receptor ACE2. The overall ACE2-binding mode of the SARS-CoV-2 RBD is nearly identical to that of the SARS-CoV RBD, which also uses ACE2 as the cell receptor4. Structural analysis identified residues in the SARS-CoV-2 RBD that are essential for ACE2 binding, the majority of which either are highly conserved or share similar side chain properties with those in the SARS-CoV RBD. Such similarity in structure and sequence strongly indicate convergent evolution between the SARS-CoV-2 and SARS-CoV RBDs for improved binding to ACE2, although SARS-CoV-2 does not cluster within SARS and SARS-related coronaviruses1-3,5. The epitopes of two SARS-CoV antibodies that target the RBD are also analysed for binding to the SARS-CoV-2 RBD, providing insights into the future identification of cross-reactive antibodies.
Comment in
-
Door to the cell for COVID-19 opened, leading way to therapies.Signal Transduct Target Ther. 2020 Jun 26;5(1):104. doi: 10.1038/s41392-020-00215-6. Signal Transduct Target Ther. 2020. PMID: 32591496 Free PMC article. No abstract available.
Similar articles
-
Structural basis of receptor recognition by SARS-CoV-2.Nature. 2020 May;581(7807):221-224. doi: 10.1038/s41586-020-2179-y. Epub 2020 Mar 30. Nature. 2020. PMID: 32225175 Free PMC article.
-
A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV.Science. 2020 May 8;368(6491):630-633. doi: 10.1126/science.abb7269. Epub 2020 Apr 3. Science. 2020. PMID: 32245784 Free PMC article.
-
Key residues of the receptor binding motif in the spike protein of SARS-CoV-2 that interact with ACE2 and neutralizing antibodies.Cell Mol Immunol. 2020 Jun;17(6):621-630. doi: 10.1038/s41423-020-0458-z. Epub 2020 May 15. Cell Mol Immunol. 2020. PMID: 32415260 Free PMC article.
-
Receptor-binding domain-specific human neutralizing monoclonal antibodies against SARS-CoV and SARS-CoV-2.Signal Transduct Target Ther. 2020 Sep 22;5(1):212. doi: 10.1038/s41392-020-00318-0. Signal Transduct Target Ther. 2020. PMID: 32963228 Free PMC article. Review.
-
Mass Spectrometry and Structural Biology Techniques in the Studies on the Coronavirus-Receptor Interaction.Molecules. 2020 Sep 10;25(18):4133. doi: 10.3390/molecules25184133. Molecules. 2020. PMID: 32927621 Free PMC article. Review.
Cited by
-
Combination of the chemokine receptor type 2 (CCR2) antagonist DMX-200 and candesartan for COVID-19: a randomised controlled trial.BMJ Open. 2024 Oct 22;14(10):e081790. doi: 10.1136/bmjopen-2023-081790. BMJ Open. 2024. PMID: 39438096 Free PMC article. Clinical Trial.
-
Association of Circulating Sex Hormones With Inflammation and Disease Severity in Patients With COVID-19.JAMA Netw Open. 2021 May 3;4(5):e2111398. doi: 10.1001/jamanetworkopen.2021.11398. JAMA Netw Open. 2021. PMID: 34032853 Free PMC article.
-
Computational investigation on Andrographis paniculata phytochemicals to evaluate their potency against SARS-CoV-2 in comparison to known antiviral compounds in drug trials.J Biomol Struct Dyn. 2021 Aug;39(12):4415-4426. doi: 10.1080/07391102.2020.1777901. Epub 2020 Jun 16. J Biomol Struct Dyn. 2021. PMID: 32543978 Free PMC article.
-
Computational evaluation of major components from plant essential oils as potent inhibitors of SARS-CoV-2 spike protein.J Mol Struct. 2020 Dec 5;1221:128823. doi: 10.1016/j.molstruc.2020.128823. Epub 2020 Jul 4. J Mol Struct. 2020. PMID: 32834111 Free PMC article.
-
Detection of Binding Sites on SARS-CoV-2 Spike Protein Receptor-Binding Domain by Molecular Dynamics Simulations in Mixed Solvents.IEEE/ACM Trans Comput Biol Bioinform. 2021 Jul-Aug;18(4):1281-1289. doi: 10.1109/TCBB.2021.3076259. Epub 2021 Aug 6. IEEE/ACM Trans Comput Biol Bioinform. 2021. PMID: 33914685 Free PMC article.
References
-
- Zhou, P. et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579, 270–273 (2020). - DOI
-
- Wu, F. et al. A new coronavirus associated with human respiratory disease in China. Nature 579, 265–269 (2020). - DOI
-
- Zhu, N. et al. A novel coronavirus from patients with pneumonia in China, 2019. N. Engl. J. Med. 382, 727–733 (2020). - DOI
-
- Li, F., Li, W., Farzan, M. & Harrison, S. C. Structure of SARS coronavirus spike receptor-binding domain complexed with receptor. Science 309, 1864–1868 (2005). - DOI
-
- Lu, R. et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 395, 565–574 (2020). - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous